lääketurvatoiminnan

Lääketurvatoiminta refers to the activities and processes involved in ensuring the safe and effective use of medicines. This encompasses a broad range of actions taken by various stakeholders, including pharmaceutical companies, regulatory authorities, healthcare professionals, and patients. The primary goal of lääketurvatoiminta is to identify, assess, understand, and prevent adverse drug reactions and other potential medication-related problems.

Key components of lääketurvatoiminta include pharmacovigilance, which is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. This involves collecting and analyzing reports of suspected adverse drug reactions, monitoring the safety profile of medicines throughout their lifecycle, and taking appropriate regulatory actions when necessary.

Pharmaceutical companies are responsible for conducting clinical trials to assess the safety and efficacy of their products before they are approved for marketing. Once a medicine is on the market, they must continue to monitor its safety and report any new information on adverse events to regulatory authorities. Regulatory agencies, such as the Finnish Medicines Agency (Fimea), play a crucial role in evaluating the safety of medicines, authorizing their use, and implementing measures to protect public health. Healthcare professionals, including doctors and pharmacists, are also vital in identifying and reporting adverse drug reactions, as well as providing guidance to patients on the safe use of medications. Patients themselves contribute by reporting any unexpected or concerning effects they experience to their healthcare providers.